tsn

Systematic Meta-Analysis Globally Shows SARS-CoV-2-Triggered MIS-C Hit Children Hard, Significant Number of Deaths

 75
2 comments
Staff at TrialSite | Quality Journalism
Oct. 9, 2024, 6:00 p.m.

Giancarlo Alvarado-Gamarra at the pediatric department in the General Hospital in Jesús María District, Lima, Peru, and colleagues report on the serious post-infectious condition linked to COVID-19 in young persons: multisystem inflammatory syndrome in children or MIS-C. With existing studies concentrating on MIS-C severity leading to various outcomes, the Peruvian authors acknowledge the difficulty to date to draw any conclusions. Enter this systematic review finding that although a low certainty evidentiary baseline, the authors find the frequency of in-hospital unfavorable outcomes in patients with MIS-C is high. Reflecting a more globalized and generalizable output, the authors introduce the world to just how severe MIS-C has been during the pandemic. Importantly authorities promoted vaccination among children, especially during the delta surge, to mitigate the risk of MIS-C.

TrialSite has chronicled studies revealing that MIS-C emerged as most severe during the delta variant of interest surge. Alvarado-Gamarra and colleagues sought to estimate the frequency of in-hospital unfavorable outcomes in patients with MIS-C over the 3 years since the onset of the SARS-CoV-2 pandemic.

Quality journalism costs money to produce.

Free access provides up to 10 articles

Subscription options start at $5 per month 
which is less than a Starbucks coffee!

Peter Gabriel, MD
"Publishing on TrialSite helped me secure a $20m research grant for my work."
Jona Savinda
"TrialSiteNews is my daily read for what is happening in the industry."
Lucas Van Der Hoven
"Objective, unbiased reporting on the latest news in medical research. I trust TrialSiteNews to give it to me straight."
TrialSiteNews
159 W Broadway, Suite 200
Salt Lake City, UT 84101
© 2025 - Trial Site News